Literature DB >> 1640554

Subureteral collagen injection for the endoscopic treatment of vesicoureteral reflux in children. Followup study of 97 treated ureters and histological analysis of collagen implants.

P Frey1, D Berger, P Jenny, B Herzog.   

Abstract

Endoscopic subureteral injection has become an established alternative means for treating vesicoureteral reflux in select children. However, which injection material to use remains a controversy. Polytetrafluoroethylene (Teflon) has been injected in more than a thousand patients with few complications, although experimental and clinical studies have demonstrated migration of the injected particles into distant organs, such as the lungs and the brain, as well as local and metastatic granuloma formation. Therefore, we introduced, following experimental studies in the mini-pig model, glutaraldehyde cross-linked, highly purified bovine collagen for injection. Between June 1988 and October 1991, 97 refluxing ureters in 66 children were treated by endoscopic subureteral collagen injection. In 58.8% of the ureters reflux was cured after 1 and in 77.3% after 2 injections. Considering improvement to grades I and II reflux without further treatment as success, the success rate increased to 68.0% after 1 and to 89.7% after 2 injections. Mean followup was 18.5 months (range 3 to 39 months). After 2 failed injections the patients either returned to antibiotic long-term prophylaxis or the reflux was operatively corrected. The operative procedure was never compromised by the preceding injection. A direct correlation between deficient length of the submucosal tunnel of the intravesical ureter and the iatrogenic malposition of the collagen deposits, and the failures could be demonstrated. Granuloma formation at the site of injection was not found. The results of the histological investigation of the collagen deposits removed at open ureteral reimplantation for failures are reported. It could be demonstrated that endogenous fibroblasts invade the bovine collagen implant and that these cells show active production of new human collagen, types I and III, replacing the implant.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1640554     DOI: 10.1016/s0022-5347(17)36703-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

Review 1.  Vesicoureteral reflux: From prophylaxis to surgery.

Authors:  Anne-Sophie Blais; Stéphane Bolduc; Katherine Moore
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

2.  Histological response to injected dextranomer-based implant in a rat model.

Authors:  Murat Alkan; Arbay O Ciftci; Beril Talim; Mehmet E Senocak; Melda Caglar; Nebil Buyukpamukcu
Journal:  Pediatr Surg Int       Date:  2006-10-17       Impact factor: 1.827

3.  Subureteral collagen injection versus antireflux surgery in primary vesico-ureteral reflux grade III.

Authors:  N Gordjani; A Frankenschmidt; L B Zimmerhackl; M Brandis
Journal:  Eur J Pediatr       Date:  1996-06       Impact factor: 3.183

Review 4.  The endoscopic treatment of incontinence in children.

Authors:  Paolo Caione; Alberto Lais
Journal:  Curr Urol Rep       Date:  2002-04       Impact factor: 3.092

5.  Endoscopic injection therapy for treatment of vesicoureteric reflux: A 20-year perspective.

Authors:  Michael P Leonard
Journal:  Paediatr Child Health       Date:  2002-10       Impact factor: 2.253

Review 6.  Does deflux alter the paradigm for the management of children with vesicoureteral reflux?

Authors:  Ian A Aaronson
Journal:  Curr Urol Rep       Date:  2005-03       Impact factor: 2.862

7.  Histological response to injected gluteraldehyde cross-linked bovine collagen based implant in a rat model.

Authors:  Murat Alkan; Beril Talim; Arbay O Ciftci; Mehmet E Senocak; Melda Caglar; Nebil Büyükpamukçu
Journal:  BMC Urol       Date:  2006-02-18       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.